I'm not saying I'm not dancing close to the door. These aquisitions are likely to be a sugar hit over the next couple of years, like you say no barriers to entry. They emphasied the R&D competitive advantage, but I more see their advantage as covering a lot of numbers on a roulette layout. Good odds, though a hit is a hit and it might not be from their stable.
I wouldn't short it, but if I did it would be in the low to mid 30s probably next year. Likely to be upgrades coming this year.
Goodluck.
Ann: 2018 Investor Day Presentation, page-11
Add ALL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$67.75 |
Change
-0.120(0.18%) |
Mkt cap ! $36.16B | |||
| Open | High | Low | Value | Volume |
| $67.77 | $68.20 | $67.42 | $51.90M | 766.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1090 | $67.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $67.77 | 20386 | 4 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| ALL (ASX) Chart |
